Immatics NV
(IMTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMTX | GLUE | INBX | ||
| Company | Immatics NV | Monte Rosa Therapeutics Inc | Inhibrx Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.97 | 18.78 | 82.30 | ||
| High | 10.21 | 18.89 | 82.30 | ||
| Low | 9.96 | 18.44 | 82.30 | ||
| Latest | 10.21 | 18.70 | 82.11 | ||
| Change | +0.31 | +0.20 | +0.19 | ||
| % Change | +3.13% | +1.08% | +0.23% | ||
| Volume | 951 | 15,750 | 133 | ||
| 20-Day Average Volume | 364,503 | 1,052,877 | 194,712 | ||
| Previous Close | 9.90 | 18.50 | 82.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.80 | 21.08 | 78.71 | ||
| 20-Day Raw Stochastic | 78.00% | 6.31% | 64.57% | ||
| 20-Day Relative Strength | 52.16 | 45.34 | 54.50 | ||
| Weighted Alpha | +107.22 | +105.11 | +274.33 | ||
| Today's Opinion | 56% Buy | 64% Buy | 88% Buy | ||
| Previous Opinion | 40% Buy | 64% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.98% since 02/06/26 | -5.65% since 02/06/26 | -1.92% since 02/06/26 | ||
| Low | 9.43 on 02/09/26 | 17.98 on 02/12/26 | 77.24 on 02/11/26 | ||
| High | 10.49 on 02/10/26 | 20.06 on 02/11/26 | 88.72 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +7.78% since 01/13/26 | -23.11% since 01/13/26 | +12.31% since 01/13/26 | ||
| Low | 8.55 on 02/05/26 | 17.98 on 02/12/26 | 70.60 on 01/20/26 | ||
| High | 10.55 on 02/03/26 | 25.35 on 01/22/26 | 88.72 on 02/09/26 | ||
| 3-Month | |||||
| %Chg | +1.30% since 11/13/25 | +28.81% since 11/13/25 | +10.29% since 11/13/25 | ||
| Low | 8.55 on 02/05/26 | 12.94 on 11/18/25 | 69.47 on 01/12/26 | ||
| High | 12.41 on 12/04/25 | 25.77 on 01/08/26 | 94.57 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +65.74% since 08/13/25 | +315.43% since 08/13/25 | +249.17% since 08/13/25 | ||
| Low | 5.05 on 09/02/25 | 4.30 on 08/21/25 | 22.40 on 08/19/25 | ||
| High | 12.41 on 12/04/25 | 25.77 on 01/08/26 | 94.57 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,203,345 | 1,204,683 | 1,194,207 | ||
| Shares Outstanding, K | 121,550 | 65,118 | 14,544 | ||
| Annual Sales | 168,630,000 | 75,620,000 | 200,000 | ||
| Annual Net Income | 16,470,000 | -72,700,000 | 1,687,570,000 | ||
| Last Quarter Sales | 6,060,000 | 12,770,000 | 1,300,000 | ||
| Last Quarter Net Income | -59,080,000 | -27,080,000 | -28,650,000 | ||
| 60-Month Beta | 1.36 | 1.61 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 11/17/25 | -0.33 on 11/06/25 | -2.28 on 11/14/25 | ||
| Latest Earnings Date | 03/26/26 | 03/19/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 59.25 | 0.00 | ||